Indo-MIM IPO Review 2026: Financials,Strengths & Risks
Indo-MIM IPO is a mainboard issue from a Bengaluru-based precision engineering company that has spent nearly three decades building the world's largest installed manufacturing capacity in Metal Injection Molding (MIM) technology.
The company makes precision components for the automotive, defence, medical, consumer and aerospace industries, running 15 manufacturing plants across India, the United States, the United Kingdom and Mexico. The ₹3,812.11 crore IPO combines a fresh issue and an offer for sale, with the fresh issue proceeds earmarked mainly for debt repayment and general corporate purposes.
For live subscription numbers and the application link, visit the Indo-MIM IPO page on IPO Ji.
Indo-MIM IPO — Quick Overview
| Particulars | Details |
|---|---|
| IPO Name | Indo-MIM Limited IPO |
| Price Band | ₹461 to ₹485 per equity share |
| Lot Size | 30 shares |
| Minimum Investment | ₹14,550 at the upper price band for retail investors, equivalent to one lot |
| Total Issue Size | ₹3,812.11 crore, comprising a fresh issue of ₹500 crore and an Offer for Sale of ₹3,312.11 crore |
| IPO Open Date | July 23, 2026 |
| IPO Close Date | July 27, 2026 |
| Allotment Date | July 28, 2026, tentative |
| Listing Date | July 30, 2026, tentative |
| Listing At | BSE and NSE |
Of the ₹3,812.11 crore issue, the fresh issue component of 1,03,09,278 shares (aggregating up to ₹500 crore) will go directly to the company, while the offer for sale of 6,82,91,022 shares (aggregating up to ₹3,312.11 crore) will go to selling shareholders. The fresh issue proceeds are earmarked for repayment or prepayment of certain outstanding borrowings (₹400.0 crore) and general corporate purposes. MUFG Intime India Private Limited (Link Intime) is the registrar, and HDFC Bank, Axis Capital, ICICI Securities, Kotak Mahindra Capital Company and SBI Capital Markets are the lead managers for the Indo-MIM IPO.
For the complete lot-size table, live subscription tracker and application link, see the Indo-MIM IPO detail page on IPO Ji.
About Indo-MIM Limited
Indo-MIM Limited, founded in 1996 and headquartered in Bengaluru, manufactures precision engineering components using Metal Injection Molding and related technologies such as investment casting, precision machining, ceramic injection molding and metal 3D printing.
In Fiscal 2025, the company produced over 6,400 products for automotive, defence, medical, consumer and aerospace customers. It operates 15 manufacturing plants across India, the US, the UK and Mexico, and served more than 1,000 customers globally.
Indo-MIM has expanded through acquisitions, including CMG Technologies, Triax Industries and Phoenix DeVentures II, and holds multiple international quality certifications.
Its promoters are Green Meadows Investments Ltd, Krishna Chivukula Jr., Raj Chivukula and Jagadamba Chandrasekhar. Promoter holding will decline from 92.94% before the IPO to 77.65% after the issue.
Indo-MIM Financial Performance
- Total income increased from ₹2,900.38 crore in FY24 to ₹3,373.97 crore in FY25, and further to ₹4,320.70 crore in FY26.
- Profit after tax rose from ₹283.73 crore in FY24 to ₹423.73 crore in FY25, and further to ₹533.54 crore in FY26.
- Total assets increased from ₹3,757.51 crore in FY24 to ₹4,140.84 crore in FY25 and further to ₹4,897.33 crore in FY26.
- Net worth grew from ₹2,050.51 crore in FY24 to ₹2,199.43 crore in FY25 and further to ₹2,819.55 crore in FY26.
- Total borrowings rose from ₹1,085.01 crore in FY24 to ₹1,247.20 crore in FY25, before easing to ₹1,090.49 crore in FY26.
Source: RHP, Indo-MIM Limited
Indo-MIM Key Strengths
- Global leadership in MIM manufacturing: Indo-MIM holds the world's largest installed capacity in Metal Injection Molding, with capability spanning the full cycle from mold design and tooling to finishing and assembly.
- Diversified product portfolio: The company supplies precision components across automotive, defence, medical, aerospace and consumer sectors, reducing dependence on any single industry.
- Consistent income and profit growth: Total income grew from ₹2,900.38 crore in FY24 to ₹4,320.70 crore in FY26, while profit after tax rose from ₹283.73 crore to ₹533.54 crore over the same period.
- Integrated global manufacturing footprint: 15 plants across India, the USA, the UK and Mexico give the company backward integration and dual-shore capacity, supporting large multinational customers.
- Broad certification base: Accreditations including NADCAP, IATF 16949 and AS9100 support Indo-MIM's ability to serve regulated industries such as aerospace, defence and medical devices.
Indo-MIM Key Risks
- No long-term customer commitments: The company operates on a purchase-order basis without binding commitments from customers, so a cancellation or reduction in orders could affect revenue and cash flows.
- Dependence on imported raw materials: Indo-MIM imports a significant share of its raw materials, exposing it to import restrictions, commodity price movements, currency fluctuations and geopolitical factors.
- Manufacturing interruption risk: With operations spread across multiple plants and geographies, the company is exposed to disruptions from equipment breakdowns, labour disputes, natural events or other unforeseen causes.
- Elevated valuation multiples: At the upper price band, the issue is priced at a post-IPO P/E of 44.95 and a Price/Book ratio of 10.63, valuation levels investors should weigh against the company's growth and return ratios.
- Large OFS component: ₹3,312.11 crore of the ₹3,812.11 crore issue is an Offer for Sale, meaning the bulk of the proceeds will go to selling shareholders rather than the company.
Indo-MIM IPO Review: Our Take
Indo-MIM operates in the specialised precision manufacturing segment, with capabilities in Metal Injection Molding and a customer base across automotive, defence, medical, aerospace and consumer industries. The company has reported growth in revenue, profit and net worth, supported by its manufacturing presence across multiple countries.
Its business is largely based on purchase orders rather than long-term contracts and involves dependence on imported raw materials. The IPO also includes a significant Offer for Sale component, while the valuation at the upper price band should be assessed in comparison with industry peers and the company’s financial performance.
Investors should review the RHP, valuation, subscription data, financial statements and disclosed risk factors before making an investment decision.
Investors should review the financials, peer valuations, and their own risk appetite before making a decision. This content is for informational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before applying.
Indo-MIM IPO Allotment Status
Allotment is tentatively expected around July 28, 2026, with listing tentatively scheduled for July 30, 2026 on BSE and NSE. Once finalised, check your status via:
- The IPO Ji app or website
- BSE or NSE websites
- The registrar's website (MUFG Intime India Private Limited / Link Intime)
You'll need your PAN, application number or Demat account details.
Check the Indo-MIM IPO allotment status on IPO Ji for quick updates.
How to Apply for Indo-MIM IPO on IPO Ji
- Open the IPO Ji App (Play Store/App Store) or visit ipoji.com.
- Search for Indo-MIM IPO.
- Review the price band, lot size and dates.
- Select your Demat account and enter the number of lots.
- Submit using your registered UPI ID and approve the mandate before the deadline.
The application amount stays blocked in your account and is debited only on allotment. ASBA via net banking or a supported broker also works.
FAQs on Indo-MIM IPO
Indo-MIM reported growth in revenue and profit from FY24 to FY26 and serves customers across multiple industries through its global manufacturing network. The IPO valuation, reliance on purchase-order-based business and the Offer for Sale component are important factors to consider.
The price band is ₹461 to ₹485 per share, and the lot size is 30 shares. The minimum retail investment at the upper price band is ₹14,550, while the maximum retail investment is ₹1,89,150 for 13 lots.
The IPO is a combination of a fresh issue of 1,03,09,278 shares, aggregating up to ₹500 crore, and an Offer for Sale of 6,82,91,022 shares, aggregating up to ₹3,312.11 crore. The total issue size is ₹3,812.11 crore.
The IPO opens on July 23, 2026, and closes on July 27, 2026. Allotment is tentatively expected around July 28, 2026, while listing is tentatively scheduled for July 30, 2026, on BSE and NSE.
Indo-MIM Limited is a global leader in precision engineering components manufactured using Metal Injection Molding technology. It also offers investment casting, precision machining, ceramic injection molding and 3D metal printing services to customers in the automotive, defence, medical, consumer and aerospace sectors.
According to the offer documents, Indo-MIM has no directly comparable listed peer in India. Its one comparable listed peer globally is Jiangsu Gian Technology Co. Ltd, which is listed on the Shenzhen Stock Exchange in China.
The fresh issue proceeds are earmarked for repayment or prepayment of certain outstanding borrowings worth ₹400 crore, along with general corporate purposes. The Offer for Sale proceeds will go to the selling shareholders.
Live QIB, NII and retail subscription data can be checked on the Indo-MIM IPO subscription status page on IPO Ji or through the official BSE and NSE websites.
Live GMP data can be checked on the Indo-MIM IPO GMP page on IPO Ji . GMP is unofficial and may change frequently.
This article is for informational purposes only and should not be construed as investment advice. Investors are advised to read the RHP/DRHP of the company carefully and consult a registered financial advisor before applying to any IPO.